Get started
Author

Emanuel Boyer

Observed names: E. Boyer, E.F. Boyer, Emanuel F Boyer, Emanuel Franklin Cecil Boyer
OpenAlex ID: A5033262231
FOLFIRINOX or Gemcitabine-based Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: A Multi-institutional, Patient-Level, Meta-analysis and Systematic Review
2023 · Dilmurodjon Eshmuminov, Botirjon Aminjonov, et al. · Annals of Surgical Oncology · 87
PDF
Delta radiomics analysis of Magnetic Resonance guided radiotherapy imaging data can enable treatment response prediction in pancreatic cancer
2021 · M. R. Tomaszewski, K. Latifi, et al. · Radiation Oncology · 47
PDF
Surgical and Pathologic Outcomes of Pancreatic Adenocarcinoma (PA) After Preoperative Ablative Stereotactic Magnetic Resonance Image Guided Adaptive Radiation Therapy (A-SMART)
2022 · J.M. Bryant, Russell F. Palm, et al. · Advances in Radiation Oncology · 18
Neoadjuvant chemotherapy and stereotactic body radiation therapy for borderline resectable pancreas adenocarcinoma: influence of vascular margin status and type of chemotherapy
2023 · Russell F. Palm, Emanuel Boyer, et al. · HPB · 4
Late Subconjunctival Emphysema in an Unrepaired Orbital Floor Fracture
2022 · Emanuel F Boyer, Oliver Filutowski, et al. · Cureus · 2
PDF
Early outcomes of irreversible electroporation after stereotactic body radiation therapy for the treatment of locally advanced pancreatic adenocarcinoma (LAPC): A matched pair analysis.
2021 · Emanuel Boyer, Russell Palm, et al. · Journal of Clinical Oncology · 1
Delta radiomics analysis of Magnetic Resonance guided radiotherapy imaging data for treatment response prediction in pancreatic cancer
2023 · Michal Tomaszewski, Kujtim Latifi, et al. · Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition
ASO Visual Abstract: FOLFIRINOX or Gemcitabine Based Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: A Multi-Institutional, Patient-Level Meta-Analysis and Systematic Review
2023 · Dilmurodjon Eshmuminov, Botirjon Aminjonov, et al. · Annals of Surgical Oncology
Pathological outcomes of pancreatic adenocarcinoma (PA) after preoperative high biological effective dose (BED) magnetic resonance image-guided radiation therapy (MRgRT).
2022 · John Michael Bryant, Russell Palm, et al. · Journal of Clinical Oncology
Impact of Tumor Dosimetry on Clinical Outcomes after Stereotactic Body Radiation Therapy for Pancreatic Adenocarcinoma
2021 · R.F. Palm, E.F. Boyer, et al. · International Journal of Radiation Oncology*Biology*Physics
A Single Institution Experience On High Dose MRI-Guided Stereotactic Body Radiotherapy For Pancreatic Cancer: Early Outcomes, Safety And Feasibility
2020 · R.F. Palm, E.F. Boyer, et al. · International Journal of Radiation Oncology*Biology*Physics
Works count: 11
Citation count: 159
H-index: 4
I10-index: 3
Year
Topic
Type